Keywords: Parkinson's Disease, Parkinson's Disease, VMAT2, striatum, iron
Motivation: The limited availability and high cost of 18F-AV133 PET impedes its widespread adoption for use in diagnosis of Parkinson’s disease.
Goal(s): Our goal was to assess the relationship between 18F-AV133 PET and MRI imaging markers in Parkinson's disease.
Approach: Magnetization transfer and relaxometry imaging metrics derived in the basal ganglia of Parkinson's disease patients were compared to standardized uptake ratios from 18F-AV133 PET.
Results: Significant correlations were seen between 18F-AV133 PET and MRI imaging metrics. These results suggest that MRI is able to capture neurodegenerative processes in Parkinson's disease.
Impact: Our demonstration of the relationship between 18F-AV133 PET and MRI imaging markers suggests MRI imaging markers may serve as a surrogate measure for the integrity of the nigrostriatal system in Parkinson's disease.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords